GoodRx Holdings, Inc. GDRX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from GoodRx Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s return on equity?
- GoodRx Holdings, Inc. (GDRX) reported return on equity of 3.2% in Q1 2026.
- How has GoodRx Holdings, Inc.'s return on equity changed year-over-year?
- GoodRx Holdings, Inc.'s return on equity decreased by 27.2% year-over-year, from 4.4% to 3.2%.
- What is the long-term trend for GoodRx Holdings, Inc.'s return on equity?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s return on equity has grown at a 8.5% compound annual growth rate (CAGR), from -3.3% to 4.5%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.